Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study
Clinical Cardiology · 2025
DOI: 10.1002/clc.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Shandong Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Uric Acid, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the National Natural Science Foundation of China (Grant 81800292), the Chunhui Project Foundation of the Education Department of Ch….
Abstract (Originalsprache)
Background
Observational studies indicate that serum urate level is associated with atrial fibrillation (AF). However, whether this association is causal remains controversial, due to confounding factors and reverse causality. We aim to evaluate the causal relationship of genetically predicted serum urate level with AF.
Methods
A bidirectional Mendelian randomization (MR) study was performed. Instrumental variables were obtained from the Global Urate Genetics Consortium (110347 individuals). We obtained summary statistics of AF from two genome‐wide association studies (GWAS) data sets for AF. Inverse‐variance‐weighted method was applied to obtain MR estimates and other statistical methods were conducted in the sensitivity analyses. The reverse MR analysis was performed to evaluate the effect of AF on serum urate levels.
Results
Genetically determined serum urate level was not associated with AF in two studies (OR, 1.03; 95% CI, 0.95–1.11; p = 0.47); (OR, 1.06; 95% CI, 0.99–1.12; p = 0.09). The main results kept robust in the most sensitivity analyses. Multivariable MR analyses suggested that the association pattern did not change, after adjusting for body mass index (BMI), HbA1c: hemoglobin A1c (HbA1c), hypertension, low‐density lipoprotein cholesterol (LDL‐C) and coronary heart disease. No causal effect of AF on serum urate levels was found in two studies (OR, 1.02; 95% CI, 0.98–1.05; p = 0.30); (OR, 1.00; 95% CI, 0.98–1.03; p = 0.95).
Conclusions
Our MR study supports no bidirectional causal effect of serum urate levels and AF. This implies that treatments aimed at lowering uric acid may not reduce the risk of AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.
- Department of Cardiology, Dazhou Central Hospital, Dazhou, Sichuan Province, China.
- School of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, China.
- School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan Province, China.
- Medical College, Sichuan University of Arts and Sciences, Dazhou, Sichuan Province, China.
Förderung
- This study was supported by the National Natural Science Foundation of China (Grant 81800292), the Chunhui Project Foundation of the Education Department of Ch…
Zitieren
APA
Yu, S., Wang, W., Gao, Y., Zhou, J., & Chu, Y. (2025). Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study. Clinical Cardiology. https://doi.org/10.1002/clc.70089
Vancouver
Yu S, Wang W, Gao Y, Zhou J, Chu Y. Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study. Clinical Cardiology. 2025. doi:10.1002/clc.70089
BibTeX
@article{Yu2025,
author = {Yu, Shandong and Wang, Wei and Gao, Yulian and Zhou, Jun and Chu, Yanpeng},
title = {Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70089}
}
EUVIMED